Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Single-Blinded Randomized Study of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology

NCT07040163 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.

NCT NCT07040163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07040163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Single-Blinded Randomized Study of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology
Lead sponsor
CAMC Health System
Phase
Phase 1
Overall status
Active, not recruiting
Start date
March 7, 2025
Completion date
June 30, 2026
Enrollment
276 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biopsy, drainage procedure, interventional radiology, sedation